Joshua Wang is the founder and CEO of VerImmune (www.verimmune.com). Before starting VerImmune, Joshua was trained at Johns Hopkins rising to the position of adjunct assistant professor before being involved in the development of a vaccine start-up as an operational founder. He then worked at Flagship Ventures in Boston, where he was part of the initial exploration that led to the discovery of the AnelloVector platform and creation of Ring Therapeutics.